Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $267.79 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $143.96 | 2 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $34.20 | 2 | $0 (2022) |
| ABBVIE INC. | $28.98 | 2 | $0 (2023) |
| IBSA Pharma Inc. | $17.09 | 1 | $0 (2021) |
| UCB, Inc. | $16.94 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $13.60 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $13.02 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.98 | 2 | ABBVIE INC. ($28.98) |
| 2022 | $107.78 | 6 | Alexion Pharmaceuticals, Inc. ($34.20) |
| 2021 | $131.03 | 2 | Janssen Pharmaceuticals, Inc ($113.94) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/02/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Rare Disease | ||||||
| 03/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Rare Disease | ||||||
| 03/01/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Immunology | ||||||
| 09/21/2021 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: Endocrinology | ||||||
| 08/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $113.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 428 | 919 | $388,838 | $79,545 |
| 2022 | 5 | 186 | 370 | $130,629 | $27,417 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 133 | 314 | $124,303 | $28,069 | 22.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 41 | 114 | $111,614 | $18,629 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 289 | $72,322 | $16,858 | 23.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 109 | 112 | $41,836 | $9,503 | 22.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 33 | $29,354 | $4,324 | 14.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 57 | $9,409 | $2,162 | 23.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 196 | $40,932 | $9,965 | 24.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 72 | $24,669 | $5,608 | 22.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 30 | $34,238 | $4,993 | 14.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 54 | 55 | $17,270 | $4,271 | 24.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $13,519 | $2,580 | 19.1% |
About Dr. Stacey Ikebudu, MD
Dr. Stacey Ikebudu, MD is a Internal Medicine healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2019. The National Provider Identifier (NPI) number assigned to this provider is 1033772298.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Ikebudu, MD has received a total of $267.79 in payments from pharmaceutical and medical device companies, with $28.98 received in 2023. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($267.79).
As a Medicare-enrolled provider, Ikebudu has provided services to 614 Medicare beneficiaries, totaling 1,289 services with total Medicare billing of $106,962. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Cartersville, GA
- Active Since 04/15/2019
- Last Updated 07/05/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033772298
Products in Payments
- XARELTO (Drug) $143.96
- SOLIRIS (Biological) $34.20
- Tirosint (Drug) $17.09
- Cimzia (Drug) $16.94
- DALVANCE (Drug) $15.42
- LOKELMA (Drug) $13.60
- TEFLARO (Drug) $13.56
- ENTRESTO (Drug) $13.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cartersville
Dr. David Kim, Md, MD
Internal Medicine — Payments: $12,616
Antonio Baute, Md, MD
Internal Medicine — Payments: $12,568
Christopher Inhulsen, Md, MD
Internal Medicine — Payments: $7,293
Sreedhar Maddineni, M.d, M.D
Internal Medicine — Payments: $4,706
Dr. Jeffrey Esslinger, M.d, M.D
Internal Medicine — Payments: $4,661
Prasad Rao, M.d, M.D
Internal Medicine — Payments: $3,679